This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone Sept 2026 quarter: revenue up 40%, PAT up 29%
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 8.0 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone results for the quarter ended September 30, 2026: revenue from operations rose 40% to Rs 2,587.48 lakh from Rs 1,852.75 lakh a year earlier, and profit after tax rose 29% to Rs 370.44 lakh from Rs 286.29 lakh. Half-year revenue was Rs 4,683.41 lakh versus Rs 3,528.46 lakh, and half-year profit after tax was Rs 706.22 lakh versus Rs 515.94 lakh. Quarterly EPS was Rs 2.94. The limited review found no material issue.
Strong quarter: revenue and profit both grew sharply, supporting sentiment, though half-year operating cash flow was only Rs 101.24 lakh.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹25.87 Cr | ₹18.53 Cr | +39.7% |
| Operating profit | ₹4.19 Cr | ₹3.09 Cr | +35.5% |
| Profit after tax | ₹3.70 Cr | ₹2.86 Cr | +29.4% |
| EBITDA margin | 17.3% | 18.2% | −0.9 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.